Only a generation ago it was a major achievement to count human chromosomes; in 1956, Tjio and Levan determined that man has 46 chromosomes. Today, cytogenetics and molecular genetics are providing important clues about the genesis of tumours and the gene therapy of cancer is approaching.
BACKGROUND
As far back as 1910, the German zoologist Theodor Boveri stated that cancer may develop from somatic alterations in the genetic material, the so-called somatic mutation theory. For a long time this theory could not be tested because mammalian chromosomes, for technical reasons, could not be visualised in enough detail. Boveri's theory was not generally accepted until the 1970s, when special staining techniques allowed chromosomes to be divided into several bands and each individual chromosome pair to be identified by its specific banding pattern. This made it possible to demonstrate the presence of recurrent tumour-associated chromosomal aberrations.
For chromosomal analysis, karyotyping, fresh tumour tissue is mechanically or enzymatically disintegrated and cultured for two to ten days in short-term culture. When these are rich in mitoses, they are harvested and the mitoses are arrested in metaphase by Colcemid. The metaphases are spread on glass slides, the chromosomes are banded by staining techniques, and are then ready for microscopic analysis (Fig. 1) .
The first association between cancer and a chromosomal aberration was reported by Nowell and Hungerford in 1960. They found a small marker chromosome, named the Philadelphia (Ph 1 ) chromosome, in cells from patients with chronic myeloid leukaemia. With the introduction of banding techniques, it was shown that the rearrangement giving rise to this marker was a translocation between chromosomes 9 and 22. This was the first consistent chromosomal abnormality found in human cancer. The discovery seemed to confirm Boveri's theory; it was assumed that the acquired chromosomal abnormality was the cause of the neoplasm.
Since then it has been generally accepted that cancer is due to somatically acquired, genetic changes caused by mutations. Some mutations may be inherited and may predispose to cancer. At the cellular level, cancer is a genetic disease; genetic changes are inherited from the neoplastic cell by all its daughter cells. During tumour progression, additional aberrations occur through genetic instability. It was earlier believed that acquired chromosomal aberrations indicated malignancy but they have now also been found in several types of benign tumour, one of the most studied being the common benign lipoma.
Many types of structural rearrangement of chromosomes have been identified in neoplastic cells, such as deletion, duplication, inversion, insertion and translocation. Such rearrangements give rise to loss, gain, and relocation of genetic material. In addition, numerical aberrations, giving rise to loss or gain of entire chromosomes, are common.
Three principal effects of chromosomal aberrations have been identified. Oncogenes are the activated form of normal genes, so-called proto-oncogenes, and act, in most cases, in a dominant way. Proto-oncogenes are thought to control cell proliferation by governing the balance between growthstimulating and growth-inhibiting factors. When a protooncogene is activated into an oncogene, this balance is disturbed and growth control is lost. The activation of oncogenes by chromosomal rearrangements has been demonstrated in several types of tumour. A well-known example is seen in Burkitt's lymphoma. By translocations to various chromosomes (2, 14 or 22 which contain the various loci for the immunoglobulin chains), the MYC proto-oncogene (on chromosome 8) is brought into contact with one of the three immunoglobulin loci and thereby activated. Protooncogenes can also be activated by other chromosomal rearrangements or, at the molecular level, by point mutations, which cannot be revealed by chromosomal analysis.
The second mechanism is the formation of a fusion gene, also known as a chimaeric or hybrid gene, leading to the production of an abnormal protein. The classic example is the Philadelphia chromosome in chronic myeloid leukaemia in which the 9;22-translocation brings two genes into contact and an abnormal hybrid protein is encoded by the fusion gene. The main consequence of many translocations is the activation of transcription factors by the formation of fusion genes. These factors activate genes and this process is considered to be important for tumorigenesis. Several tumour-specific translocations which lead to the formation of fusion proteins have been identified, not only in haematological malignancies, but also in sarcomas (Fig. 2 ) (for review, see Rabbitts 1994) .
The third mechanism is inactivation of a tumour suppressor gene. These are normal genes that regulate cell growth, and which act in a recessive way at the cellular level. Inactivation of both alleles may lead to abnormal cell growth. For example, the loss of both retinoblastoma genes (RB1) on both chromosomes 13 results in the formation of retinoblastoma and also plays a role in the development of osteosarcoma. Constitutional, mutational inactivation of one of the RB1 genes and somatic mutation of the other leads to earlier onset and often the bilateral development of retinoblastoma.
More than 20 000 neoplasms with chromosomal aberrations have been reported; three-quarters of them are in haematological malignancies. The under-representation of solid tumours is due to earlier technical difficulties with shortterm tissue culturing and chromosomal preparations. There are three main findings in leukaemias and lymphomas: 1) Various tumour types have different kinds of chromosomal aberration, some of which seem to be pathognomonic.
2) The parts of the chromosomes that are involved in the aberrations contain genes that are of importance for tumorigenesis.
3) The chromosomal aberrations are of clinical importance; they are useful for diagnosis as well as prognosis.
Most solid tumours are the common epithelial cancers such as carcinomas of the breast, colon, lung, kidney and prostate, which cause most cancer morbidity and mortality. Much less cytogenetic data are available for these tumours, Schematic presentation. To the left are the two chromosomes 11 and to the right the two chromosomes 22. In each pair the chromosome on the left is normal, whereas that on the right is engaged in the translocation. The distal parts of the affected chromosomes are exchanged, as indicated by arrows. New genes are created where translocated material from one chromosome is fused to the other. partly because of technical difficulties, but also because of the highly complex karyotypes with multiple aberrations that are hard to interpret.
Another group of solid malignant tumours is the rare musculoskeletal tumours, the bone and soft-tissue sarcomas, which comprise only about 1% of all malignancies although they arise from the largest tissue compartment of the body. By contrast, benign musculoskeletal tumours are common, especially soft-tissue tumours such as the ubiquitous lipoma and its variants.
Earlier technical difficulties with chromosomal preparations now seem to have been overcome. As a result, an increasing number of benign and malignant musculoskeletal tumours with chromosomal aberrations are being reported; by now more than 1000 cases have been described. The findings in haematological malignancies seem to hold true also for musculoskeletal tumours; the various tumour types have characteristic chromosomal aberrations, some of which may be pathognomonic, and many of these result in specific molecular rearrangements. They can already be used for diagnostic purposes, but little is known about their prognostic importance.
CHROMOSOMAL ABERRATIONS
Benign musculoskeletal tumours (Table I) . Specific chromosomal aberrations have been found in several benign tumours. Lipomatous tumours have been investigated, and despite the monotonous histological appearance of the ordinary solitary lipoma, several cytogenetic subgroups have been identified (Mandahl et al 1994) . Chromosome 12 is involved in most groups. Ring chromosomes appear in both atypical lipoma and well-differentiated liposarcoma. If these tumours were the same, this would explain the pathologist's difficulties in differentiating between them. Specific chromosomal aberrations have also been found in other rare lipomatous tumours such as hibernoma, lipoblastoma, spindle-cell lipoma and pleomorphic lipoma. Very little is known about the molecular consequences of the chromosomal aberrations in benign tumours, but recently the involvement of the HMGIC gene in chromosome 12 has been identified in lipomas. Malignant musculoskeletal tumours (Table II) . Ewing's sarcoma, leiomyosarcoma, liposarcoma, malignant fibrous histiocytoma (MFH), osteosarcoma, rhabdomyosarcoma and synovial sarcoma are the most investigated tumours. Leiomyosarcoma, the highly malignant, storiform-pleomorphic variant of MFH, and osteosarcoma all have complex chromosomal aberrations. Parosteal osteosarcoma, the myxoid type of MFH, dermatofibrosarcoma protuberans, and well-differentiated liposarcoma, all relatively less malignant, are characterised by supernumerary ring chromosomes. Ewing's sarcoma, myxoid liposarcoma, alveolar rhabdomyosarcoma, and synovial sarcomas all have specific translocations, and the genes involved are known. On the basis of these findings, benign and malignant musculoskeletal tumours can be divided into four groups.
Tumours that show consistent chromosomal aberrations
This group includes the ordinary lipoma and several benign lipomatous tumour variants: atypical lipoma/well-differentiated liposarcoma, lipoblastoma, spindle-cell and pleomorphic lipoma, and hibernoma. Among the malignant lipomatous tumours, myxoid liposarcoma has a characteristic translocation, t(12;16) (Fig. 3) . Other tumours in this group include neurilemmoma, clear-cell sarcoma, extraskeletal myxoid chondrosarcoma, desmoplastic small round-cell tumour, Ewing's sarcoma, PNET, alveolar rhabdomyosarcoma, and synovial sarcoma. Tumours that seem to have consistent chromosomal aberrations. Benign and malignant cartilage tumours, parosteal osteosarcoma, chordoma, dermatofibrosarcoma protuberans, childhood fibrosarcoma, and haemangiopericytoma may be characterised by specific chromosomal aberrations. The number of reported cases, however, is still low. Tumours with no detectable characteristic patterns. Chromosomal aberrations have been found in several cases of fibromatosis, fibrosarcoma in adults, giant-cell tumour, leiomyosarcoma, malignant fibrous histiocytoma, neurofibrosarcoma, osteosarcoma and embryonal rhabdomyosarcoma. No specific aberrations, however, have been found. The aberrations in leiomyosarcoma, osteosarcoma and highly malignant fibrous histiocytoma are very complex and therefore impossible to karyotype in detail. Tumours of which an insufficient number have been analysed. Since several musculoskeletal tumours have been analysed in small numbers only, it is not yet possible to draw any conclusions as to whether they harbour tumourspecific chromosomal aberrations (see notes to Table I and  II) .
The clinical importance of chromosomal aberrations in musculoskeletal tumours is still limited, but it is rapidly increasing. Some of the aberrations are already of diagnostic importance. Cytogenetic and in particular molecular genetic analyses for diagnostic purposes require minute amounts of tissue; these can be obtained by fine-needle aspiration.
TUMOUR CLASSIFICATION
The histopathological classification of musculoskeletal tumours is difficult; there is an ongoing reclassification of well-known types of tumour and new clinicopathological entities are still being defined. The tumours are rare; few pathologists therefore have much experience and they do not always agree among themselves. Examination by immunohistochemistry and electron microscopy have improved 12 16 the diagnoses, but there is a need for additional diagnostic markers. In several cases, cytogenetic findings seem to be of biological and diagnostic importance. One example is that of Ewing's sarcoma and PNET, which share the same and specific translocation t(11;22). These tumour types are now regarded as variants of the same neuroectodermal tumour. The t(11;22) or variants of it have been found in 90% of Ewing's sarcomas; the finding of this translocation therefore favours that diagnosis in cases in which the histopathology is not clear. The histopathological diagnosis of synovial sarcoma may be controversial, especially regarding the monophasic spindle-cell variant. The finding of t(X;18) in both the mono and biphasic variants of synovial sarcoma indicates a close relationship between these types of tumour and strengthens the diagnosis of synovial sarcoma.
Some 90% of the synovial sarcomas examined carry the X;18 translocation. It is not clear whether all synovial sarcomas have this translocation or may carry other alterations or whether all tumours with this translocation are indeed synovial sarcomas. This question is also relevant for other sarcomas with chromosomal aberrations. Difficulties in the histological typing of particularly highly-malignant sarcomas make it hard to answer this question. If tumours with, for example, an X;18 translocation have the same biology, regardless of their different histological appearance, they could perhaps be classified by the chromosomal aberration and be called X;18 sarcomas.
The t(12;16) translocation seems to be specific to subgroups of liposarcomas; 90% of myxoid tumours have such an aberration. The finding of this translocation also in round-cell liposarcomas seems to justify the sometimes questioned relationship between these types of tumour. The karyotypic findings in various benign but rare lipomatous tumours may also be of diagnostic importance.
Extremely low-grade parosteal osteosarcomas may mimic histologically a completely benign osteochondroma. These tumours show different karyotypic changes which can be used for differential diagnosis Fig. 4) . When more data on other types of tumour become available, further specific chromosomal aberrations will probably be found to have diagnostic importance.
TISSUE SAMPLING
Diagnosis. Most surgeons consider that open biopsy is necessary for the diagnosis of musculoskeletal tumours. It does, however, have several disadvantages; wound infection may delay definitive treatment and a misplaced incision as well as local tumour spread may complicate later radical surgery.
In our department we have used fine-needle aspiration for a long period to diagnose benign and malignant musculoskeletal tumours. We have found this method reliable, especially for adult soft-tissue sarcoma of which the exact histotype is of no importance in the surgical management: in A 20-year-old man had a lesion of the distal femur which was excised. The histological findings were evaluated as a benign exostosis. Cytogenetic analyses, however, showed a ring chromosome. Although chromosomal aberrations have been found in benign exostoses they usually involve chromosome 8. The finding of a ring chromosome made the diagnosis of a parosteal osteosarcoma more probable. The slides were re-evaluated by several pathologists, without knowledge of the chromosomal aberration, and their diagnosis was a low-grade parosteal osteosarcoma. The patient had a reoperation with a wide excision. most cases a diagnosis of sarcoma suffices. To increase the diagnostic reliability, we have also used fine-needle aspirates for chromosomal analysis. In a series of 6 osteosarcomas and 12 Ewing's sarcomas, chromosomal aberrations were found in 2 osteosarcomas and 7 Ewing's sarcomas, 5 of which had the characteristic 11;22 translocation (Fig. 5) . This finding strongly supported the cytological diagnosis. Both the PCR (polymerase chain reaction) technique to detect the hybrid mRNA (used in one of our cases with a positive result) or the FISH (fluorescence in situ hybridization) technique to identify the translocation, may be used on fine-needle aspirates. These should also be applicable to other tumour types. Prognosis. Hitherto, few data have been available concerning the association between chromosomal aberrations and the prognosis in musculoskeletal tumours. In general, there seems to be a correlation between increasingly complex karyotypes and a poor prognosis. Classic osteosarcoma and malignant fibrous histiocytoma of the storiform pleomorphic type, both high-grade malignant tumours, most often have complex chromosomal aberrations. In contrast, the presence of supernumerary ring chromosomes may be the sole structural change found in parosteal osteosarcoma, dermatofibrosarcoma protuberans, myxoid MFH, and well-differentiated liposarcoma/atypical lipoma; they seem to be a feature of tumours of borderline or low malignancy (Orndal et al 1992) . Preliminary findings in giant-cell tumours of bone indicate an association between the presence or absence of chromosomal aberrations and the risk of recurrence (Bridge, Neff and Mouron 1992) . In chondromatous tumours, increasingly complex aberrations have been found to correlate with an increasing grade of malignancy (Bridge et al 1993) .
CONCLUSIONS
Benign and malignant musculoskeletal tumours carry various, specific chromosomal aberrations. Several of the genes involved in these aberrations, especially translocations, have been identified. The specific chromosomal aberrations can be used for diagnostic purposes. Preliminary findings indicate that they may also be of prognostic value.
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Fig. 5a Tumour of the femur in an eight-year-old boy (a). Fine-needle aspiration showed a small round-cell tumour. Part of the aspirate was cultured for three days; chromosomal analysis showed an 11;22 translocation (b). The diagnosis of Ewing's sarcoma was confirmed without open biopsy.
